PCPat G. Camp

Pat G. Camp

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Pat G. Camp has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • David A. Lomas

    Department of Medicine, University of Cambridge, Cambridge, UK

    1 shared publication
  • Denis E. O'DOnnell

    Division of Respiratory and Critical Care Medicine, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada

    1 shared publication
  • Dirkje S. Postma

    Department of Pulmonology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    1 shared publication
  • Donald Sin

    Faculty of Medicine, Respiratory Division, University of British Columbia, Vancouver

    1 shared publication
  • Edwin K. Silverman

    Channing Laboratory and Pulmonary and Critical Care Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    1 shared publication
  • Harvey O. Coxson

    James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, University of British Columbia, Vancouver, BC, Canada; Department of Radiology, University of British Columbia, Vancouver, BC, Canada

    1 shared publication

Latest Publications

  • Sex Differences in Emphysema and Airway Disease in Smokers

    by Pat G. Camp, Harvey O. Coxson, Robert D. Levy, Sreekumar G. Pillai, Wayne Anderson, Jørgen Vestbo, Susan M. Kennedy, Edwin K. Silverman, David A. Lomas, Peter D. Paré


  • Chronic Obstructive Pulmonary Disease in Men and Women: Myths and Reality

    by Pat G. Camp, Denis E. O'DOnnell, Dirkje S. Postma

    Chronic diseases have a variable impact on men and women due to the complex interaction between biological sex and environmental risk factors to which men and women are differentially exposed. Sex differences have not been adequately explored in chronic obstructive pulmonary disease (COPD), as most studies have either had small sample sizes or not enough women to allow for accurate comparisons. This article will address sex differences in susceptibility, expression of COPD subtypes, and activity-related breathlessness, and will identify key areas for further investigation.


  • Open Access

    The Sex Factor: Epidemiology and Management of Chronic Obstructive Pulmonary Disease in British Columbia

    by Pat G Camp, Munaza Chaudhry, Howard Platt, Michael Roch, Jeremy Road, Donald Sin, Robert D Levy

    BACKGROUND: The prevalence and mortality of chronic obstructive pulmonary disease (COPD) in women have been predicted to overtake that of men within the next decade. These predictions are based in part on data from surveys using self‐reports of a COPD diagnosis. Whether these predictions have been realized is unknown.METHODS: The prevalence and mortality of men and women in British Columbia were compared from fiscal years 1992/1993 to 2003/2004 using administrative health services data. Case definitions for COPD were developed using International Classification of Diseases ninth and 10th revision (ICD‐9/10) codes applied to medical and hospital data. Individuals 45 years and older, who had at least two physician visits or one hospitalization for specified COPD ICD‐9/10 codes within a 365‐day window, were considered to be cases. Cases were ascertained from 1992 to 2004.RESULTS: In 2003/2004, men had a greater prevalence (4.7% versus 4.0% in women) and a higher all‐cause mortality rate (5.4% versus 4.1% in women) than women. Both men and women with COPD had low COPD medication use (45%) and low referral for lung function testing (55%). Including the ICD‐9 code for ‘bronchitis, not specified as acute or chronic’ (ICD‐9 490) in the case definition resulted in a greater prevalence of COPD in women than in men overall, and in the 45 to 64 year age group.CONCLUSION: Prevalence and mortality measured with administrative health data do not show evidence of relative increase in the prevalence of COPD for women in British Columbia. However, further analysis of ICD‐9 490 may identify an early ‘at‐risk’ group, specifically in women.


  • Gender and the Diagnosis, Management, and Surveillance of Chronic Obstructive Pulmonary Disease

    by Pat G. Camp, Sarah M. Goring

    Following in the footsteps of cardiovascular researchers and clinicians, the pulmonary scientific community is beginning to explore how gender may impact the diagnosis, treatment, and surveillance of chronic obstructive pulmonary disease (COPD). Investigators and clinicians in this field are tackling the complex questions surrounding how differences in male/female biology may interact with gender differences in environmental, societal, cultural, and behavioral determinants of health to influence outcomes in COPD. In this article, issues such as gender differences in symptoms, gender diagnostic bias, differential impact of therapies, including smoking cessation and pharmacologic management, as well as the impact of these issues on COPD surveillance, are discussed. Current knowledge from the literature coupled with discussions from a 1-day symposium on gender and COPD diagnosis, management, and surveillance are detailed, including recommendations on where future research endeavors may be targeted.